178 related articles for article (PubMed ID: 33141958)
1. Inter-observer evaluation of erythema-directed photography for the assessment of erythema and telangiectasias in rosacea.
Dall'Oglio F; Verzi AE; Lacarrubba F; Giuffrida G; Milani M; Micali G
Skin Res Technol; 2021 Jul; 27(4):521-525. PubMed ID: 33141958
[TBL] [Abstract][Full Text] [Related]
2. Treatment of erythemato-telangiectatic rosacea with brimonidine alone or combined with vascular laser based on preliminary instrumental evaluation of the vascular component.
Micali G; Dall'Oglio F; Verzì AE; Luppino I; Bhatt K; Lacarrubba F
Lasers Med Sci; 2018 Aug; 33(6):1397-1400. PubMed ID: 28889348
[TBL] [Abstract][Full Text] [Related]
3. Erythema-directed digital photography and colorimeter scores correlate with rosacea erythema evaluation in patients under treatment with topical ivermectin.
Dall'Oglio F; Lacarrubba F; Micali G
Dermatol Ther; 2021 May; 34(3):e14920. PubMed ID: 33641260
[TBL] [Abstract][Full Text] [Related]
4. Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study.
Eichenfield LF; Del Rosso JQ; Tan JKL; Hebert AA; Webster GF; Harper J; Baldwin HE; Kircik LH; Stein-Gold L; Kaoukhov A; Alvandi N
Br J Dermatol; 2019 May; 180(5):1050-1057. PubMed ID: 30500065
[TBL] [Abstract][Full Text] [Related]
5. Reliability of Clinician Erythema Assessment grading scale.
Tan J; Liu H; Leyden JJ; Leoni MJ
J Am Acad Dermatol; 2014 Oct; 71(4):760-3. PubMed ID: 24999270
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a simple image-based tool to quantify facial erythema in rosacea during treatment.
Logger JGM; de Jong EMGJ; Driessen RJB; van Erp PEJ
Skin Res Technol; 2020 Nov; 26(6):804-812. PubMed ID: 32537843
[TBL] [Abstract][Full Text] [Related]
7. Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severity.
Wienholtz NKF; Thyssen JP; Christensen CE; Thomsen SF; Karmisholt KE; Jemec GBE; Lomholt HB; Heidenheim M; Simonsen AB; Sand C; Vestergaard C; Kaur-Knudsen D; Ammitzbøll E; Lørup E; Danielsen AG; Strauss G; Skov L; Andersen PH; Hald M; Idorn LW; Ashina M; Zachariae C; Egeberg A
J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):573-580. PubMed ID: 36331365
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of VISIA system in evaluating the severity of rosacea.
Pan Y; Jia K; Yan S; Jiang X
Skin Res Technol; 2022 Sep; 28(5):740-748. PubMed ID: 35818722
[TBL] [Abstract][Full Text] [Related]
9. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy.
Deaver Peterson J; Katz TM
J Cosmet Dermatol; 2019 Dec; 18(6):1758-1764. PubMed ID: 31017734
[TBL] [Abstract][Full Text] [Related]
10. Clinical and erythema-directed imaging evaluation of papulo-pustular rosacea with topical ivermectin: a 32 weeks duration study.
Dall'Oglio F; Lacarrubba F; Luca M; Boscaglia S; Micali G
J Dermatolog Treat; 2019 Nov; 30(7):703-707. PubMed ID: 30663445
[No Abstract] [Full Text] [Related]
11. Evaluating and Optimizing the Diagnosis of Erythematotelangiectatic Rosacea.
Saleem MD; Wilkin JK
Dermatol Clin; 2018 Apr; 36(2):127-134. PubMed ID: 29499796
[TBL] [Abstract][Full Text] [Related]
12. Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser: a case series.
Kapicioglu Y; Sarac G; Cenk H
Lasers Med Sci; 2019 Feb; 34(1):93-98. PubMed ID: 30097757
[TBL] [Abstract][Full Text] [Related]
13. Inter-observer agreement between two observers for bovine digital dermatitis identification in New Zealand using digital photographs.
Yang DA; Laven RA
N Z Vet J; 2019 May; 67(3):143-147. PubMed ID: 30753789
[TBL] [Abstract][Full Text] [Related]
14. Development and clinical validation of a novel photography-based skin erythema evaluation system: a comparison with the calculated consensus of dermatologists.
Cho M; Lee DH; Doh EJ; Kim Y; Chung JH; Kim HC; Kim S
Int J Cosmet Sci; 2017 Aug; 39(4):426-434. PubMed ID: 28178365
[TBL] [Abstract][Full Text] [Related]
15. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
Baumann L; Goldberg DJ; Stein Gold L; Tanghetti EA; Lain E; Kaufman J; Weng E; Berk DR; Ahluwalia G
J Drugs Dermatol; 2018 Mar; 17(3):290-298. PubMed ID: 29537447
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Erythematotelangiectatic Rosacea With Pulsed-Dye Laser and Oxymetazoline 1.0% Cream: A Retrospective Study.
Suggs AK; Macri A; Richmond H; Munavalli G; Friedman PM
Lasers Surg Med; 2020 Jan; 52(1):38-43. PubMed ID: 31709571
[TBL] [Abstract][Full Text] [Related]
17. Topical brimonidine reduces IPL-induced erythema without affecting efficacy: A randomized controlled trial in patients with facial telangiectasias.
Vissing AE; Dierickx C; Karmisholt KE; Haedersdal M
Lasers Surg Med; 2018 Dec; 50(10):1002-1009. PubMed ID: 29911352
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of facial vascular skin diseases with a 577-nm pro-yellow laser.
Mohamed EM; Mohamed Tawfik K; Hassan Ahmad W
J Cosmet Dermatol; 2019 Dec; 18(6):1675-1679. PubMed ID: 31033204
[TBL] [Abstract][Full Text] [Related]
19. [Persistent erythema and edema of the face associated with rosacea and lymph vessel dysplasia].
Jansen T; Regele D; Schirren CG; Trautner B; Plewig G
Hautarzt; 1998 Dec; 49(12):932-5. PubMed ID: 9914893
[TBL] [Abstract][Full Text] [Related]
20. Dermatology: how to manage rosacea in skin of colour.
Maliyar K; Abdulla SJ
Drugs Context; 2022; 11():. PubMed ID: 35720055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
